Gliquidone

CAS No. 33342-05-1

Gliquidone ( Gliquidone; Glurenorm; Beglynor; Glikvidon; Glycvidon )

Catalog No. M14125 CAS No. 33342-05-1

Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 31 In Stock
50MG 42 In Stock
100MG 51 In Stock
200MG 75 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gliquidone
  • Note
    Research use only, not for human use.
  • Brief Description
    Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.
  • Description
    Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release.
  • Synonyms
    Gliquidone; Glurenorm; Beglynor; Glikvidon; Glycvidon
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    33342-05-1
  • Formula Weight
    527.63
  • Molecular Formula
    C27H33N3O6S
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 6 mg/mL (11.37 mM); DMSO: 105 mg/mL (199.0 mM)
  • SMILES
    CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C
  • Chemical Name
    1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Angel I, et al. Fundam Clin Pharmacol, 1991, 5(2), 107-115.
molnova catalog
related products
  • DCEBIO

    DCEBIO stimulates the secretion of Cl- through the activation of the hIK1 K + channel and the activation of the apical Cl- conductance.

  • NS 1619

    NS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.

  • Rimtuzalcap

    Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels).